Dr. Edward Fox provides deeper insight into the relapse data for TECFIDERA in clinical trials and the importance of their implications.
Dr. Aaron Boster discusses physical disability progression in RMS and how he works to delay its course.
Drs. Jeffrey Dunn, Ann Cabot, Barbara O’Connell, and Joshua Katz go over the important conversations they have with their RMS patients during therapy selection and initiation.
*All videos were edited to comply with applicable laws and regulations.